skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes

Journal Article · · Biochemical and Biophysical Research Communications
;  [1]; ;  [2]
  1. Faculty of Chemical Sciences, University of Concepción, Concepción (Chile)
  2. Malopolska Centre of Biotechnology, Jagiellonian University, Kraków (Poland)

Highlights: • Labetalol is one of the most used drugs for the treatment of hypertension. • Structural and thermotropic perturbations in DMPC and DMPE lipid bilayers were induced by labetalol. • Labetalol produced morphological alterations in human erythrocytes inducing the formation of stomatocytes. Labetalol is one of the most used drugs for the treatment of hypertension. This molecule is able to bind to both alpha-1 (α1) and beta (β) adrenergic receptors present in vascular smooth muscle among other tissues. It has been determined that human erythrocytes possess both alpha receptors and beta-adrenergic receptors expressed on their surface. The objective of this work was to study the effect of labetalol on the morphology of human erythrocytes. To accomplish this goal, human erythrocytes and model membranes built of dimyristoylphosphatidylcholine (DMPC) and dimyristoylphosphatidylethanolamine (DMPE) were used. These lipid species are present in the outer and inner monolayers of the red blood cell membrane, respectively. Our findings obtained by X-ray diffraction and differential scanning calorimetry (DSC) indicate that labetalol interacted with both lipids in a process dependent on concentration. In fact, at low concentrations labetalol preferentially interacted with DMPE. On the other hand, results obtained by scanning electron microscopy (SEM) showed that labetalol alters the normal biconcave form of erythrocytes to stomatocytes and knizocytes (cells with one or more cavities, respectively). According to the bilayers couple hypothesis, this result implied that the drug inserted in the inner monolayer of the human erythrocyte membrane.

OSTI ID:
23105688
Journal Information:
Biochemical and Biophysical Research Communications, Vol. 503, Issue 1; Other Information: Copyright (c) 2018 Elsevier Inc. All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0006-291X
Country of Publication:
United States
Language:
English

Similar Records

In vitro effects of the anti-Alzheimer drug memantine on the human erythrocyte membrane and molecular models
Journal Article · Sun Jan 29 00:00:00 EST 2017 · Biochemical and Biophysical Research Communications · OSTI ID:23105688

Effects of phenylpropanolamine (PPA) on in vitro human erythrocyte membranes and molecular models
Journal Article · Fri Mar 18 00:00:00 EDT 2011 · Biochemical and Biophysical Research Communications · OSTI ID:23105688

Human erythrocytes and neuroblastoma cells are affected in vitro by Au(III) ions
Journal Article · Fri Jun 25 00:00:00 EDT 2010 · Biochemical and Biophysical Research Communications · OSTI ID:23105688